ASX - By Stock
|
MSB |
Re:
Time to buy MSB and ride the wave ?
|
|
littlefeat
|
144 |
53K |
3 |
31/07/23 |
31/07/23 |
ASX - By Stock
|
144
|
53K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
littlefeat
|
1.0K |
383K |
6 |
08/03/23 |
08/03/23 |
ASX - By Stock
|
1.0K
|
383K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2022, The TurnAround
|
|
littlefeat
|
1.0K |
322K |
4 |
30/11/22 |
30/11/22 |
ASX - By Stock
|
1.0K
|
322K
|
4
|
|
ASX - By Stock
|
LBL |
Re:
Today’s Movement - LBL
|
|
littlefeat
|
10 |
7.0K |
0 |
29/11/22 |
29/11/22 |
ASX - By Stock
|
10
|
7.0K
|
0
|
|
ASX - By Stock
|
QHL |
Re:
Ann: AGM Presentation and Chair's Address
|
|
littlefeat
|
17 |
6.3K |
1 |
16/11/22 |
16/11/22 |
ASX - By Stock
|
17
|
6.3K
|
1
|
|
ASX - By Stock
|
CTP |
Re:
Ann: NZO: Palm Valley - 12 Drilling Update
|
|
littlefeat
|
24 |
8.7K |
0 |
16/10/22 |
16/10/22 |
ASX - By Stock
|
24
|
8.7K
|
0
|
|
Charts
|
MSB |
Re:
MSB - Chart
|
|
littlefeat
|
248 |
104K |
1 |
10/10/22 |
10/10/22 |
Charts
|
248
|
104K
|
1
|
|
ASX - By Stock
|
CAQ |
Re:
Ann: Half Yearly Report and Accounts
|
|
littlefeat
|
2 |
926 |
0 |
10/10/22 |
10/10/22 |
ASX - By Stock
|
2
|
926
|
0
|
|
ASX - By Stock
|
BRN |
Re:
Ann: Notification regarding unquoted securities - BRN
|
|
littlefeat
|
4 |
3.2K |
1 |
06/10/22 |
06/10/22 |
ASX - By Stock
|
4
|
3.2K
|
1
|
|
ASX - By Stock
|
ATX |
Re:
Ann: CEO Resignation
|
|
littlefeat
|
22 |
6.7K |
1 |
12/09/22 |
12/09/22 |
ASX - By Stock
|
22
|
6.7K
|
1
|
|
ASX - By Stock
|
ATX |
Re:
Ann: First Patient Recruited to ACCENT Trial in Pancreatic Cancer
|
|
littlefeat
|
58 |
18K |
3 |
19/08/22 |
19/08/22 |
ASX - By Stock
|
58
|
18K
|
3
|
|
ASX - By Stock
|
ATX |
Re:
Ann: First Patient Recruited to ACCENT Trial in Pancreatic Cancer
|
|
littlefeat
|
58 |
18K |
1 |
18/08/22 |
18/08/22 |
ASX - By Stock
|
58
|
18K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Director Appointment
|
|
littlefeat
|
54 |
18K |
8 |
18/08/22 |
18/08/22 |
ASX - By Stock
|
54
|
18K
|
8
|
|
ASX - By Stock
|
ATX |
Re:
Ann: First Patient Recruited to ACCENT Trial in Pancreatic Cancer
|
|
littlefeat
|
58 |
18K |
10 |
02/08/22 |
02/08/22 |
ASX - By Stock
|
58
|
18K
|
10
|
|
ASX - By Stock
|
CCE |
Re:
Good news or bad news for CCE?
|
|
littlefeat
|
18 |
6.8K |
2 |
01/08/22 |
01/08/22 |
ASX - By Stock
|
18
|
6.8K
|
2
|
|
ASX - By Stock
|
MFF |
Re:
Ann: Appendix 3Y
|
|
littlefeat
|
2 |
1.1K |
0 |
01/08/22 |
01/08/22 |
ASX - By Stock
|
2
|
1.1K
|
0
|
|
ASX - By Stock
|
CCE |
Re:
Good news or bad news for CCE?
|
|
littlefeat
|
18 |
6.8K |
3 |
01/08/22 |
01/08/22 |
ASX - By Stock
|
18
|
6.8K
|
3
|
|
ASX - By Stock
|
QHL |
Re:
Pentagon and Lockheed reach deal to build 375 F-35 fighter jets
|
|
littlefeat
|
2 |
802 |
1 |
28/07/22 |
28/07/22 |
ASX - By Stock
|
2
|
802
|
1
|
|
ASX - By Stock
|
MSB |
Re:
MSB $1 Party
|
|
littlefeat
|
1.1K |
320K |
3 |
21/07/22 |
21/07/22 |
ASX - By Stock
|
1.1K
|
320K
|
3
|
|
ASX - By Stock
|
BCT |
Re:
Ann: Bluechiip banks $1.1 million R&D Tax Incentive Refund
|
|
littlefeat
|
4 |
1.9K |
1 |
08/07/22 |
08/07/22 |
ASX - By Stock
|
4
|
1.9K
|
1
|
|
ASX - By Stock
|
BCT |
Re:
Ann: Bluechiip banks $1.1 million R&D Tax Incentive Refund
|
|
littlefeat
|
4 |
1.9K |
0 |
29/06/22 |
29/06/22 |
ASX - By Stock
|
4
|
1.9K
|
0
|
|
ASX - By Stock
|
LBL |
Re:
Ann: LBL Appoints Non-Executive Director
|
|
littlefeat
|
4 |
1.6K |
0 |
09/05/22 |
09/05/22 |
ASX - By Stock
|
4
|
1.6K
|
0
|
|
ASX - By Stock
|
LBL |
Re:
Ann: LBL Appoints Non-Executive Director
|
|
littlefeat
|
4 |
1.6K |
0 |
09/05/22 |
09/05/22 |
ASX - By Stock
|
4
|
1.6K
|
0
|
|
ASX - By Stock
|
QHL |
Re:
Ann: Operational Update
|
|
littlefeat
|
25 |
10K |
2 |
22/04/22 |
22/04/22 |
ASX - By Stock
|
25
|
10K
|
2
|
|
ASX - By Stock
|
BCT |
Re:
2022 General Discussion
|
|
littlefeat
|
48 |
19K |
0 |
13/04/22 |
13/04/22 |
ASX - By Stock
|
48
|
19K
|
0
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Ethics Clearance Phase 2 Trial - Pancreatic Cancer Patients
|
|
littlefeat
|
11 |
4.0K |
0 |
06/04/22 |
06/04/22 |
ASX - By Stock
|
11
|
4.0K
|
0
|
|
Breaking News
|
|
NSW Floods
|
|
littlefeat
|
3 |
906 |
1 |
28/02/22 |
28/02/22 |
Breaking News
|
3
|
906
|
1
|
|
ASX - By Stock
|
G6M |
Re:
G6M - Charts, Chat & News
|
|
littlefeat
|
209 |
107K |
0 |
21/02/22 |
21/02/22 |
ASX - By Stock
|
209
|
107K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: 36-Month Results of Phase 3 Trial in Chronic Low Back Pain
|
|
littlefeat
|
373 |
87K |
15 |
12/01/22 |
12/01/22 |
ASX - By Stock
|
373
|
87K
|
15
|
|
ASX - By Stock
|
BRN |
Re:
Mercedes uses Akida
|
|
littlefeat
|
1.0K |
429K |
7 |
06/01/22 |
06/01/22 |
ASX - By Stock
|
1.0K
|
429K
|
7
|
|
ASX - By Stock
|
BRN |
Re:
Mercedes uses Akida
|
|
littlefeat
|
1.0K |
429K |
2 |
06/01/22 |
06/01/22 |
ASX - By Stock
|
1.0K
|
429K
|
2
|
|
ASX - By Stock
|
BRN |
Re:
Mercedes uses Akida
|
|
littlefeat
|
1.0K |
429K |
1 |
05/01/22 |
05/01/22 |
ASX - By Stock
|
1.0K
|
429K
|
1
|
|
ASX - By Stock
|
BRN |
Re:
Mercedes uses Akida
|
|
littlefeat
|
1.0K |
429K |
9 |
05/01/22 |
05/01/22 |
ASX - By Stock
|
1.0K
|
429K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on FDA Meeting for Remestemcel-L in Paediatric GvHD
|
|
littlefeat
|
211 |
72K |
3 |
31/12/21 |
31/12/21 |
ASX - By Stock
|
211
|
72K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
A Lesson from Osiris
|
|
littlefeat
|
66 |
20K |
4 |
24/12/21 |
24/12/21 |
ASX - By Stock
|
66
|
20K
|
4
|
|
ASX - By Stock
|
QHL |
Re:
F35s losing its shine
|
|
littlefeat
|
3 |
1.6K |
0 |
22/12/21 |
22/12/21 |
ASX - By Stock
|
3
|
1.6K
|
0
|
|
ASX - By Stock
|
LBL |
Re:
Ann: Pause in Trading
|
|
littlefeat
|
1 |
539 |
1 |
15/12/21 |
15/12/21 |
ASX - By Stock
|
1
|
539
|
1
|
|
ASX - By Stock
|
LBL |
Re:
breakout
|
|
littlefeat
|
2 |
1.3K |
0 |
25/11/21 |
25/11/21 |
ASX - By Stock
|
2
|
1.3K
|
0
|
|
ASX - By Stock
|
MAH |
Re:
Under The Radar
|
|
littlefeat
|
214 |
106K |
6 |
05/11/21 |
05/11/21 |
ASX - By Stock
|
214
|
106K
|
6
|
|
ASX - By Stock
|
CCE |
Re:
MoorPower
|
|
littlefeat
|
142 |
52K |
2 |
14/10/21 |
14/10/21 |
ASX - By Stock
|
142
|
52K
|
2
|
|
ASX - By Stock
|
CCE |
Re:
MoorPower
|
|
littlefeat
|
142 |
52K |
0 |
14/10/21 |
14/10/21 |
ASX - By Stock
|
142
|
52K
|
0
|
|
ASX - By Stock
|
LBL |
Re:
Ann: Investor Presentation
|
|
littlefeat
|
5 |
2.4K |
1 |
21/09/21 |
21/09/21 |
ASX - By Stock
|
5
|
2.4K
|
1
|
|
ASX - By Stock
|
LBL |
Re:
Ann: Investor Presentation
|
|
littlefeat
|
5 |
2.4K |
5 |
14/09/21 |
14/09/21 |
ASX - By Stock
|
5
|
2.4K
|
5
|
|
ASX - By Stock
|
CTP |
Re:
Gas fired recovery
|
|
littlefeat
|
35 |
16K |
0 |
31/08/21 |
31/08/21 |
ASX - By Stock
|
35
|
16K
|
0
|
|
ASX - By Stock
|
LBL |
Re:
Ann: LaserBond 2021 Performance Summary
|
|
littlefeat
|
12 |
4.6K |
3 |
23/08/21 |
23/08/21 |
ASX - By Stock
|
12
|
4.6K
|
3
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
littlefeat
|
10K |
3.0M |
1 |
10/08/21 |
10/08/21 |
ASX - By Stock
|
10K
|
3.0M
|
1
|
|
ASX - By Stock
|
VML |
Re:
Ann: Vital Increases Focus on US Investor Market with Tectonic
|
|
littlefeat
|
66 |
25K |
4 |
09/08/21 |
09/08/21 |
ASX - By Stock
|
66
|
25K
|
4
|
|
ASX - By Stock
|
ZNO |
Re:
Microsoft Deal
|
|
littlefeat
|
67 |
25K |
0 |
20/07/21 |
20/07/21 |
ASX - By Stock
|
67
|
25K
|
0
|
|
ASX - By Stock
|
MAH |
Re:
Ann: BUSINESS UPDATE
|
|
littlefeat
|
4 |
2.1K |
3 |
20/07/21 |
20/07/21 |
ASX - By Stock
|
4
|
2.1K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: COVID ARDS Trial 90-Day Survival Outcomes Presented at ISCT
|
|
littlefeat
|
251 |
90K |
2 |
19/07/21 |
19/07/21 |
ASX - By Stock
|
251
|
90K
|
2
|
|